Denmark· DK-28104555609
Hirobriz Breezhaler
A indacaterol product containing indacaterolmaleat, registered in Denmark by Novartis Europharm Limited. The same ATC class is registered in 13 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Indacaterol is registered in 13 of 19 countries.
Countries holding a registration under ATC R03AC18 (indacaterol), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Indacaterol · ATC R03AC18
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of indacaterol costs, country by country.
Normalised to the WHO defined daily dose (0.15 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Indacaterol · price per daily dose (0.15 mg)
USD · FX 28 Sept 2026
- CH Switzerland$2.16
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- indacaterolmaleat
- Manufacturer
- Novartis Europharm Limited
- Country
- Denmark (DK)
- ATC code
- R03AC18
- ATC class
- Indacaterol
- Defined daily dose
- 0.15 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28104555609
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
529 interactions on record for indacaterol.
Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Indacaterol · interactions on record
529 records
- 20 severe
- 408 moderate
- 101 minor
Most severe, free to view
- PindololC07AA03severe
- PropranololC07AA05severe
- TimololC07AA06severe
- SotalolC07AA07severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under R03AC18
Indacaterol, as other registers publish it.
- FinlandHirobriz BreezhalerNovartis Europharm Limited
- PolandHirobriz BreezhalerNovartis Europharm Limited
- DenmarkHirobriz BreezhalerNovartis Europharm Limited
- IcelandHirobriz BreezhalerNovartis Europharm Limited*
- FinlandHirobriz BreezhalerNovartis Europharm Limited
- PolandHirobriz BreezhalerNovartis Europharm Limited
- IcelandHirobriz BreezhalerNovartis Europharm Limited*
- CzechiaHIROBRIZ BREEZHALERNovartis Europharm Limited, Dublin
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8ca48cea-43d5-48ae-97bb-5353d5b8a3cd GET /v1/drugs/8ca48cea-43d5-48ae-97bb-5353d5b8a3cd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "inhalationspulver, hård kapsel",
"source": "dkma",
"strength": "150 microgram",
"auth_role": "RAP",
"dk_drugid": "28104555609",
"substance": "indacaterolmaleat",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "40147"
}See everything about indacaterol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.